Breaking News

The ‘five pandemics’ driving 1 million U.S. Covid deaths; telehealth aims to fix Paxlovid's prescription bottleneck

     

 

Daily Recap

The 'five pandemics' driving 1 million U.S. Covid deaths

By J. Emory Parker

Brynn Anderson/AP

It is clear that, when it comes to deadliness, there were five different pandemics — depending on when and where you lived, and who you were.

Read More

Telehealth aims to crack open Paxlovid's prescription bottleneck

By Katie Palmer

Bloomberg photo by Kobi Wolf

Getting a prescription for Paxlovid to treat Covid-19 is challenging. Patients and public health agencies are looking to telehealth to help .

Read More

STAT+: Pfizer to buy Biohaven for $11.6 billion, raising hopes for the broader biotech market

By Matthew Herper

Mark Lennihan/AP

Investors are likely to see the deal as a sign that large pharma companies might finally start purchasing smaller biotech firms.

Read More

Firearm deaths and disparities both grew in pandemic's first year

By Elizabeth Cooney

Adobe

Guns were used in more than three-quarters of homicides in the U.S. during the first year of pandemic, jumping 35% from 2019 to 2020.

Read More

Opinion: The faces of Covid

By Alex Goldstein

STAT/Handout

We remember the 1 million Americans who have died from Covid because each of these faces of Covid had dignity, meaning, and worth.

Read More

Watch: A STAT reporter's race to keep up with Covid-19

By Alex Hogan

As the U.S. crosses 1 million Covid-19 deaths, STAT's Helen Branswell reflects on what we've experienced during the past two-plus years.

Read More

STATUS List Spotlight: Sisters Oni and Uché Blackstock talk about their mother and impactful moments in their careers

By Nicholas St. Fleur

Drs. Uché and Oni Blackstock sit down with STAT's Nicholas St. Fleur to discuss their early life, big moments in their careers, and the future.

Read More

STAT+: It took years, but the failure of Northwest Bio's brain cancer vaccine is now in the open

By Adam Feuerstein

After years of delays and excuses, the company disclosed final results from a late-stage clinical trial of its personalized cancer vaccine.

Read More

STAT+: Why a controversial patent rights waiver could be a 'missed opportunity' to tackle the next pandemic

By Ed Silverman

Paul White/AP

Adopting a controversial Covid-19 patent waiver would be a 'missed opportunity' to tackle the next pandemic, one expert argues.

Read More

Tuesday, May 10, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments